eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
NOWOŚĆ
Portal dla gastroenterologów!
www.egastroenterologia.pl
SCImago Journal & Country Rank
1/2022
vol. 17
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł oryginalny

Association between gastrointestinal symptoms and disease severity in patients with COVID-19 in Tehran City, Iran

Elena Lak
1
,
Seyed Amir Sheikholeslami
2
,
Mahmoud Dehghani Ghorbi
3
,
Mostafa Shafei
4
,
Homayon Yosefi
5

1.
Department of Gastroenterology, School of Medicine, Imam Hossein Hospital Shahid Beheshti University of Medical Science, Tehran, Iran
2.
Department of Adult Haematology and Oncology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3.
Department of Haematology and Oncology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4.
School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5.
Department of Oncology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Gastroenterology Rev 2022; 17 (1): 52–58
Data publikacji online: 2021/05/18
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction
It is important to identify the relationship between COVID-19 and gastrointestinal symptoms for health organizations in different communities. Aim: To assess the relationship between gastrointestinal symptoms and COVID-19.

Material and methods
It was a cross-sectional descriptive-analytical study that was conducted on 381 patients those where admitted to Imam Hossein Hospital with a confirmed diagnosis of COVID-19 on nasopharyngeal polymerase chain reaction testing for SARS-CoV-2 from first March to end of June in Tehran city; 2020. Data was entered and analyzed by using SPSS version 22 and level of significant was consider less than 0.05.

Results
Out of all the patients with COVID-19, 164 (43%) had gastrointestinal symptoms. The most symptoms of them were nausea (19.2%), vomiting (17.2%), abdominal pain (15.7%), diarrhoea (12.6%), haematomas (1%), melena (1.6%), rectal bleeding (1.6%), and constipation (1.8%), respectively. The mean D-dimer1 value was significantly different between the 2 groups with gastrointestinal symptoms and no gastrointestinal symptoms. In other words, there is a strong relationship between the variable D-dimer1, which is one of the important symptoms showing the severity of COVID-19 disease, and gastrointestinal symptoms (p < 0.0001).

Conclusions
Our finding shows a statistical relationship between the level of D-dimer and gastrointestinal symptoms in patients with COVID-19. The mortality rate was higher in patients with gastrointestinal symptoms, which is an important outcome for gastroenterologists.

© 2024 Termedia Sp. z o.o.
Developed by Bentus.